Policies and rulemaking

Policies: The board approved policies to guide its work when it was first established in June 2022. Each year, the board reviews the policies and amends them, if needed. 

Rulemaking: The board may adopt rules in accordance with applicable provisions under ORS Chapter 183. During the rulemaking process the public is encouraged to submit comments to provide feedback by signing up for and attending board meetings and hearings. Information about the rules advisory committees are posted on the PDAB RAC webpage. 

2024 annual fees paid by drug manufacturers

• Draft rule text
  
• Statement of Need and Fiscal Impact
• Watch the June 25, 2024 hearing
  
• Watch the March 7, 2024 Rules Advisory Committee
  
• Committee roster
  

• OAR 925-200-0010
  
• OAR 925-200-0020
• Prescription drug affordability review
• Hearing officer report
  

2022 procedural rule

• Model rules for rulemaking and public records requests
• Hearing officer report

PDAB rulemaking advisory committees and public hearings

• Click here to watch past meetings or see the hearing schedule

Policies

• PDAB Policy 1
• Delegation Policy 2
• Conflict of Interest Policy 3
• Conflict of Interest Form
• Public Comment Policy 4

Statutory authority

• Oregon Revised Statutes for PDAB: ORS 646A.685 (UPL) and ORS 646A.693-697 (PDAB)
• Oregon Administrative Rules for PDAB:OAR Chapter 925
• Legislation for PDAB:Senate Bill 844 and Senate Bill 192